175 related articles for article (PubMed ID: 2663725)
1. Cellular immune responses of leprosy contacts to fractionated Mycobacterium leprae antigens.
Lee SP; Stoker NG; Grant KA; Handzel ZT; Hussain R; McAdam KP; Dockrell HM
Infect Immun; 1989 Aug; 57(8):2475-80. PubMed ID: 2663725
[TBL] [Abstract][Full Text] [Related]
2. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
[TBL] [Abstract][Full Text] [Related]
3. T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae.
Gulle H; Schoel B; Chiplunkar S; Gangal S; Deo MG; Kaufmann SH
Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):44-53. PubMed ID: 1602193
[TBL] [Abstract][Full Text] [Related]
4. Preliminary study of cellular immunity to Mycobacterium leprae protein in contacts and leprosy patients.
Rada EM; Santaella C; Aranzazu N; Convit J
Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):189-94. PubMed ID: 1522361
[TBL] [Abstract][Full Text] [Related]
5. Lymphoproliferative responses of leprosy patients and healthy controls to nitrocellulose-bound M. leprae antigens.
Sachdeva G; Kaur G; Bhutani LK; Bamezai RN
Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):133-42. PubMed ID: 10472365
[TBL] [Abstract][Full Text] [Related]
6. The use of antigen-bearing nitrocellulose particles derived from Western blots to study proliferative responses to 27 antigenic fractions from Mycobacterium leprae in patients and controls.
Filley E; Abou-Zeid C; Waters M; Rook G
Immunology; 1989 May; 67(1):75-80. PubMed ID: 2661418
[TBL] [Abstract][Full Text] [Related]
7. Cellular, humoral, and gamma interferon responses to Mycobacterium leprae and BCG antigens in healthy individuals exposed to leprosy.
Converse PJ; Ottenhoff TH; Gebre N; Ehrenberg JP; Kiessling R
Scand J Immunol; 1988 May; 27(5):515-25. PubMed ID: 3131867
[TBL] [Abstract][Full Text] [Related]
8. Limiting dilution analysis of the human T cell response to mycobacterial antigens from BCG vaccinated individuals and leprosy patients.
Brett SJ; Kingston AE; Colston MJ
Clin Exp Immunol; 1987 Jun; 68(3):510-20. PubMed ID: 3308217
[TBL] [Abstract][Full Text] [Related]
9. Presence of human T-cell responses to the Mycobacterium leprae 45-kilodalton antigen reflects infection with or exposure to M. leprae.
Macfarlane A; Mondragon-Gonzalez R; Vega-Lopez F; Wieles B; de Pena J; Rodriguez O; Suarez y de la Torre R; de Vries RR; Ottenhoff TH; Dockrell HM
Clin Diagn Lab Immunol; 2001 May; 8(3):604-11. PubMed ID: 11329466
[TBL] [Abstract][Full Text] [Related]
10. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
[TBL] [Abstract][Full Text] [Related]
11. Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T-cell responses to antigens in M. leprae nonresponders.
Thole JE; Janson AA; Kifle A; Howe RC; McLean K; Nurilygn A; Filley E; Shannon EJ; Bulla GJ; Hermans J
Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):369-80. PubMed ID: 7594920
[TBL] [Abstract][Full Text] [Related]
12. T-cell stimulation with purified mycobacterial antigens in patients and healthy subjects infected with Mycobacterium leprae: secreted antigen 85 is another immunodominant antigen.
Launois P; Niang MN; Sarthou JL; Rivier F; Drowart A; Van Vooren JP; Millan J; Huygen K
Scand J Immunol; 1993 Aug; 38(2):167-76. PubMed ID: 8346416
[TBL] [Abstract][Full Text] [Related]
13. T-cell recognition of the 18-kilodalton antigen of Mycobacterium leprae.
Dockrell HM; Stoker NG; Lee SP; Jackson M; Grant KA; Jouy NF; Lucas SB; Hasan R; Hussain R; McAdam KP
Infect Immun; 1989 Jul; 57(7):1979-83. PubMed ID: 2659530
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
15. Immunological cytokine correlates of protective immunity and pathogenesis in leprosy.
Lima MC; Pereira GM; Rumjanek FD; Gomes HM; Duppre N; Sampaio EP; Alvim IM; Nery JA; Sarno EN; Pessolani MC
Scand J Immunol; 2000 Apr; 51(4):419-28. PubMed ID: 10736116
[TBL] [Abstract][Full Text] [Related]
16. Molecular study of the T cell repertoire in family contacts and patients with leprosy.
Mendez-Samperio P; Lamb J; Bothamley G; Stanley P; Ellis C; Ivanyi J
J Immunol; 1989 May; 142(10):3599-604. PubMed ID: 2497176
[TBL] [Abstract][Full Text] [Related]
17. Cellular and humoral immune responses to recombinant 65-kD antigen of Mycobacterium leprae in leprosy patients and healthy controls.
Ilangumaran S; Shanker Narayan NP; Ramu G; Muthukkaruppan VR
Clin Exp Immunol; 1994 Apr; 96(1):79-85. PubMed ID: 8149671
[TBL] [Abstract][Full Text] [Related]
18. Comparison of various preparations of Mycobacterium leprae and other mycobacteria by lymphocyte stimulation.
Bjune G
Int J Lepr Other Mycobact Dis; 1978; 46(3-4):386-93. PubMed ID: 83309
[TBL] [Abstract][Full Text] [Related]
19. A postgenomic approach to identification of Mycobacterium leprae-specific peptides as T-cell reagents.
Dockrell HM; Brahmbhatt S; Robertson BD; Britton S; Fruth U; Gebre N; Hunegnaw M; Hussain R; Manandhar R; Murillo L; Pessolani MC; Roche P; Salgado JL; Sampaio E; Shahid F; Thole JE; Young DB
Infect Immun; 2000 Oct; 68(10):5846-55. PubMed ID: 10992494
[TBL] [Abstract][Full Text] [Related]
20. In vitro stimulation of lymphocytes in leprosy patients, healthy contacts of leprosy patients, and subjects not exposed to leprosy. Comparison of an antigen fraction prepared from Mycobacterium leprae and tuberculin-purified protein derivative.
Closs O; Reitan LJ; Negassi K; Harboe M; Belehu A
Scand J Immunol; 1982 Aug; 16(2):103-15. PubMed ID: 6182610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
